Attention Deficit-Hyperactivity Disorder Clinical Trial
Official title:
Toll-Like Receptor Polymorphism, Antinuclear Antibodies and Beta-hemolytic Group A Streptococcus Infections in Attention-Deficit/Hyperactivity Disorder: an Observational Study
The aim of this observational cross-sectional study is to evaluate the streptococcal infection (clinical history, ASLO title and anti-DNAse title B) and autoimmunity (ABGA antibodies) in a sample of 100 adult patients diagnosed with ADHD (ie in patients in whom the disorder is permanent). Another objective will be to evaluate the frequency and types of genetic alterations of innate immunity (TLR polymorphisms, MyD88, IRAK-4) that can determine an infantile susceptibility to gram positive infections (ie S. pyogenes, S. pneumoniae, S. aureus) and the possible relationship between these elements, also in relation to comorbidity with other ABGA-related pathologies, to identify a possible pathogenetic immune mechanism of ADHD. Prevalence data will be obtained on an outpatient ADHD population for previous (history) and recent streptococcal infection (ASLO and Anti-DNAsiB), for the detection of ABGA and for the co-presence of other ABGA-related pathologies. By comparing the subgroups obtained by dividing the results on the basis of the positive infectious history, anti-streptococcus, autoantibody and comorbidity titers, it will be possible to assess whether the elevation of the ABGA titer is only linked to the previous/current infection ("infectious" group) or if there is a subpopulation of ADHD patients presenting pathological elevation of ABGA titers in the absence of infectious pictures ("immune" group). Furthermore, it is expected that the comparison of the descriptive polymorphisms TLR, MyD88 and IRAK-4 between the "infectious" and "immune" group may show a predisposition in subjects of the "immune" group.
Attention Deficit / Hyperactivity Disorder (ADHD) is the most widespread neurodevelopmental
disorder (prevalence 3-7% in preschool age) and is characterized by persistent inattention
and / or hyperactivity-impulsivity which results in significant impairment in at least two
areas of operation (usually scholastic / working and relational) with consequent impact even
on the child's self-esteem. It is estimated that one-third of children with ADHD continue to
be affected in adulthood and that around one-third have remission of symptoms with persisting
changes in functioning and development of psychiatric disorders in adulthood (eg anxiety
disorders mood and personality). The pathogenetic model of ADHD is still poorly
characterized: several biological, psychological and environmental causes have been
identified that would seem to interact in a complex way in determining the pathology. Several
studies have hypothesized and confirmed an association between streptococcal infections,
increased titer of antibodies to the basal nuclei (ABGA), different neurological and
psychiatric disorders (eg, Sydenham chorea, Tic Disorders, Obsessive-Compulsive Disorder) and
ADHD. ADHD is diagnosed in 40% of autoimmune neuropsychiatric disorders associated with
streptococcal infection (PANDAS) and Sydenham Korea and a temporal connection between onset /
exacerbation of ADHD and pharyngeal streptococcal infection has been described in literature.
High titers of anti-streptococcal antibodies and larger size of putamen and pallidum were
found in ADHD patients. However, the permanence of symptoms ADHD at a distance from
streptococcal infection has led to hypothesize, as already done for PANDAS and Sydenham
Korea, a miminking mechanism with consequent cross-reactivity towards host tissues that would
support an autoimmune disorder characterized by the production of ABGA.
According to some authors, therefore, ADHD and other ABGA-related neurological and
psychiatric disorders (eg, Sydenham Korea, Tic Disorders, Obsessive-Compulsive Disorder)
would be different phenotypic manifestations of a common immunological disorder affecting the
nuclei of the base, triggered from group A beta-hemolytic streptococcus. The search for ABGA
in ADHD patients with Tic Disorders and Obsessive-Compulsive Disorder has largely confirmed
this hypothesis, however, the finding of ABGA titres in ADHD patients without comorbidities
with other ABGA-related disorders is still controversial. A first study found no differences
significant in terms of ABGA positivity frequency among ADHD patients without ABGA related
disorders and controls while a more recent study conducted confirmed that children with ADHD
without ABGA-related disorders are more frequently positive for ABGA than the control group
(30% vs 4.8%; χ2 = 4.33; p = 0.04) and that, among these, those with Anti-Streptolysinic
Title (ASLO) show significantly higher percentages of ABGA positivity (χ2 = 10.95; p <.001).
On the other hand, greater susceptibility by ADHD patients to contracting streptococcal
infections was confirmed by the finding of significantly higher titers of ASLO and anti-DNAse
B in ADHD patients.
The predisposition to infections and the high familiarity of ADHD (90% of cases have at least
one affected parent), suggest an immune pathogenetic mechanism based on a genetic
predisposition.
Although several studies have established, in an inconclusive way, a relationship between
ADHD and some regulatory genes, the major histocompatibility complex (MHC), such as HLA-DR4,
HLA-DRB1 and C4B, to date no one has yet evaluated the role of Toll-type receptor (TLR)
genes, which are more responsible for innate immunity, ie the recognition of pathogenic
structural molecules. In particular, some variants of the TLR genes could affect the immune
response to strepotococcus or other pathogens, favoring damage to the nuclei of the base
which would in turn lead to ADHD symptoms. Recently, an association between susceptibility to
serious or recurrent infections from group A beta-hemolytic streptococcus, Streptococcus
pneumoniae, Haemophilus influenza and particular polymorphisms of TLR2, TLR4 and TLR9 has
been demonstrated. The altered functioning consequent to these TLR polymorphisms could
explain both the vulnerability to certain types of pathogens responsible for lesions to the
central nervous system (among which the most studied so far is Group A beta-hemolytic
streptococcus), whether the incongruous or excessive immune activation even in the absence of
contact with pathogens producing autoantibodies against the nerve structures of the base
nuclei.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04152629 -
Real World Evidence of the Efficacy and Safety of FOQUEST
|
Phase 4 | |
Completed |
NCT03003286 -
Community Based Intervention for Children With ADHD and ASD
|
N/A | |
Completed |
NCT01831622 -
Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder
|
Phase 4 | |
Completed |
NCT03847402 -
The Early Integrated Intervention for Child Brain-developmental Disorders in China
|
N/A | |
Withdrawn |
NCT01769300 -
Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT03440346 -
Biomarker Research in ADHD: the Impact of Nutrition
|
N/A | |
Completed |
NCT04689282 -
Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders
|
Phase 1/Phase 2 | |
Recruiting |
NCT02778360 -
Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder
|
Phase 1/Phase 2 | |
Completed |
NCT04228094 -
Assesment of TDApp1 an eHelath Tool to Make Therapeutic Recommendations for Patients With ADHD
|